MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-28 Cr | ₹-37 Cr | ₹76 Cr | ₹19 Cr | ₹155 Cr |
What is the latest Net Cash Inflow / Outflow ratio of MANKIND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-28 Cr |
| Mar2025 | ₹-37 Cr |
| Mar2024 | ₹76 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹155 Cr |
How is Net Cash Inflow / Outflow of MANKIND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-28 Cr | Negative | |
| Mar2025 | ₹-37 Cr | Negative | |
| Mar2024 | ₹76 Cr | 290.95 | |
| Mar2023 | ₹19 Cr | -87.48 | |
| Mar2022 | ₹155 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹109,899.3 Cr | 5.1% | 12.3% | 8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 7.3% | 8.4% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 15.3% | 24.1% | 63% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 1% | 2.5% | 33.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | 1% | 15.9% | 14% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 0.4% | 7.9% | -6.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 5.1% |
12.3% |
8.8% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses